BETHESDA, MD 16 October 2013—FDA announced yesterday that B. Braun Medical Inc. has recalled
one lot of cefepime in the Duplex drug delivery system after finding visible organic particulates in a retained sample of the product.
The recalled lot, H3A744, contains 1 g of cefepime for injection plus dextrose for injection packaged in Duplex conainers.
The medication and its diluent occupy separate compartments in the container until it is activated for use.
The recalled lot is labeled with an expiration date of January 2015 and was shipped nationwide this year from February 4 to March 1.
Anyone with the recalled product on hand should immediately cease using it and contact the company at 800-227-2862, Monday through Friday, 8 a.m. to 7 p.m. Eastern Time, for information about returning and replacing the product.
According to the company, no adverse events related to the recall have been reported. Patients who have problems that may be related to the use of the recalled product should contact their health care provider and report the problem to B. Braun at 800-854-6851.
For questions, comments, or
more information on this
article, please contact the
ASHP News Center at firstname.lastname@example.org.
Stay connected with ASHP through our social media tools.
What We Do
For the Press
Jobs at ASHP
AHFS Drug Information
Customer Service: 1-866-279-0681
8:00am - 6:00pm ET, Mon-Fri
American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814